Inactive Instrument

News Summit Corporation plc London S.E.

Equities

GB00B02T3K57

End-of-day quote London S.E. Other stock markets
- ^GBX	-

Jul. 01	Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell Small Cap Comp Value Index	CI
Jul. 01	Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Growth Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	Jul. 04	AQ
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jul. 03	BU
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell Small Cap Comp Value Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Growth Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 3000 Value Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 2500 Value Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 2000 Value Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 3000E Growth Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 3000E Value Index	Jun. 30	CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 3000E Index	Jun. 30	CI
Summit Therapeutics Inc. Enters into Two Sublease Agreements with Genius 24C Inc. and Duggan Investments Research LLC	Jun. 27	CI
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors	Jun. 27	BU
Summit Therapeutics Inc. Appoints Jeff Huber to Its Board of Directors	Jun. 27	CI
Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer	Jun. 24	CI
Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Chief Financial Officer	Jun. 24	CI
Summit Therapeutics Inc. announced that it has received $199.999998 million in funding from Baker Bros. Advisors LP	Jun. 17	CI
Summit Therapeutics Inc. Announces Resignation of Ujwala Mahatme as Member of its Board	Jun. 13	CI
Sector Update: Health Care Stocks Steady Premarket Monday	Jun. 03	MT
Stifel Adjusts Summit Therapeutics Price Target to $14 From $8, Maintains Buy Rating	Jun. 03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Summit Corporation plc London S.E.

Equities

GB00B02T3K57

Summary

Filters